Evidence map›Paper›PMID 41351663›Full record

ReviewMolecular neurobiology2025

Navigating the Autophagy Maze: ATG and Their Impact on Neurodegenerative Diseases.

Roshanak Amirian, AmirHossein Merati, Mehregan Babamohamadi, Yasaman Mirahmadi, Mahsa Loran Esfahani, Shahla Rahmani, Zhila Izadi, Davood Rezazadeh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Roshanak AmirianStudent Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
AmirHossein MeratiStudent Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Mehregan BabamohamadiDepartment of Biology, School of Natural Sciences, University of Tabriz, Tabriz, Iran.
Yasaman MirahmadiDepartment of Medical Laboratory Sciences, School of Paramedical, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Mahsa Loran EsfahaniDepartment of Medical Laboratory Sciences, School of Allied Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Shahla RahmaniPharmaceutical Sciences Research Center Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Zhila IzadiPharmaceutical Sciences Research Center Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. izadi.zhila@yahoo.com.
Davood RezazadehMolecular Medicine Department, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. davoodrez@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy, a tightly regulated process essential for maintaining cellular homeostasis, plays a critical role in the pathogenesis and progression of neurodegenerative diseases (NDs). These disorders-marked by diverse mechanisms and clinical heterogeneity-pose significant challenges in developing effective therapies. Central to the autophagic machinery are autophagy-related genes (ATGs), whose functions and variants are increasingly recognized as pivotal in modulating disease-specific pathways. This review explores the intricate roles of ATGs in NDs, emphasizing the need for a comprehensive understanding of molecular signaling networks, protein-protein interactions, and regulatory checkpoints that may serve as therapeutic targets. We highlight recent advancements in disease modeling, autophagy assays, and biomarker identification that facilitate the translation of ATG-related discoveries into clinical practice. Furthermore, we underscore the importance of interdisciplinary collaboration across academia, industry, clinical medicine, and regulatory bodies to harness the therapeutic potential of autophagy. This article aims to serve as a detailed roadmap for understanding the role of ATGs in NDs and to illuminate promising avenues for future research and therapeutic development.

Indexed as

AutophagyAutophagy-Related ProteinsNeurodegenerative DiseasesAnimalsHumansSignal TransductionAutophagy-Related ProteinsAlzheimer’s disease (AD)Amyotrophic lateral sclerosis (ALS)AutophagyAutophagy genes (ATG)Huntington’s disease (HD)Neurodegenerative diseases (NDs)Parkinson’s disease (PD)

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.